Literature DB >> 16525717

Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development.

Beat Trueb1, Sara Taeschler.   

Abstract

FGFRL1 is a novel member of the fibroblast growth factor receptor (FGFR) family. To investigate its expression during mammalian embryonic development, we have used the mouse system. Expression of Fgfrl1 is very low in mouse embryos of day 6 but steadily increases until birth. As demonstrated by in situ hybridization of 16-day-old embryos, the Fgfrl1 mRNA occurs in cartilaginous structures such as the primordia of bones and the permanent cartilage of the trachea, the ribs and the nose. In addition, some muscle types, including the muscles of the tongue and the diaphragm, express Fgfrl1 at relatively high level. In contrast, the heart and the skeletal muscles of the limbs, as well as many other organs (brain, lung, liver, kidney, gut) express Fgfrl1 only at basal level. It is conceivable that Fgfrl1 interacts with other Fgfrs, which are expressed in cartilage and muscle, to modulate FGF signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525717

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  15 in total

1.  Rapid fusion and syncytium formation of heterologous cells upon expression of the FGFRL1 receptor.

Authors:  Florian Steinberg; Simon D Gerber; Thorsten Rieckmann; Beat Trueb
Journal:  J Biol Chem       Date:  2010-09-17       Impact factor: 5.157

2.  Fibroblast growth factor receptor 5 (FGFR5) is a co-receptor for FGFR1 that is up-regulated in beta-cells by cytokine-induced inflammation.

Authors:  Romario Regeenes; Pamuditha N Silva; Huntley H Chang; Edith J Arany; Andrey I Shukalyuk; Julie Audet; Dawn M Kilkenny; Jonathan V Rocheleau
Journal:  J Biol Chem       Date:  2018-09-14       Impact factor: 5.157

3.  Prioritization of Candidate Genes for Congenital Diaphragmatic Hernia in a Critical Region on Chromosome 4p16 using a Machine-Learning Algorithm.

Authors:  Danielle A Callaway; Ian M Campbell; Samantha R Stover; Andres Hernandez-Garcia; Shalini N Jhangiani; Jaya Punetha; Ingrid S Paine; Jennifer E Posey; Donna Muzny; Kevin P Lally; James R Lupski; Chad A Shaw; Caraciolo J Fernandes; Daryl A Scott
Journal:  J Pediatr Genet       Date:  2018-05-30

4.  Examination of FGFRL1 as a candidate gene for diaphragmatic defects at chromosome 4p16.3 shows that Fgfrl1 null mice have reduced expression of Tpm3, sarcomere genes and Lrtm1 in the diaphragm.

Authors:  Nelson LopezJimenez; Simon Gerber; Vlad Popovici; Sonia Mirza; Kirsten Copren; Linda Ta; Gary M Shaw; Beat Trueb; Anne M Slavotinek
Journal:  Hum Genet       Date:  2009-12-19       Impact factor: 4.132

5.  Fine-grained facial phenotype-genotype analysis in Wolf-Hirschhorn syndrome.

Authors:  Peter Hammond; Femke Hannes; Michael Suttie; Koen Devriendt; Joris Robert Vermeesch; Francesca Faravelli; Francesca Forzano; Susan Parekh; Steve Williams; Dominic McMullan; Sarah T South; John C Carey; Oliver Quarrell
Journal:  Eur J Hum Genet       Date:  2011-07-27       Impact factor: 4.246

6.  Comparison of the receptor FGFRL1 from sea urchins and humans illustrates evolution of a zinc binding motif in the intracellular domain.

Authors:  Lei Zhuang; Andrei V Karotki; Philip Bruecker; Beat Trueb
Journal:  BMC Biochem       Date:  2009-12-18       Impact factor: 4.059

7.  Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice.

Authors:  Catarina Catela; Daniel Bilbao-Cortes; Esfir Slonimsky; Paschalis Kratsios; Nadia Rosenthal; Pascal Te Welscher
Journal:  Dis Model Mech       Date:  2009-04-21       Impact factor: 5.758

8.  The FGFRL1 receptor is shed from cell membranes, binds fibroblast growth factors (FGFs), and antagonizes FGF signaling in Xenopus embryos.

Authors:  Florian Steinberg; Lei Zhuang; Michael Beyeler; Roland E Kälin; Primus E Mullis; André W Brändli; Beat Trueb
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

9.  Wolf-Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions.

Authors:  Hannelie Engbers; Jasper J van der Smagt; Ruben van 't Slot; Joris R Vermeesch; Ron Hochstenbach; Martin Poot
Journal:  Eur J Hum Genet       Date:  2008-10-01       Impact factor: 4.246

10.  FGFRL1 is a neglected putative actor of the FGF signalling pathway present in all major metazoan phyla.

Authors:  Stephanie Bertrand; Ildiko Somorjai; Jordi Garcia-Fernandez; Thomas Lamonerie; Hector Escriva
Journal:  BMC Evol Biol       Date:  2009-09-09       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.